Package: MetaGxOvarian 1.33.0

Benjamin Haibe-Kains

MetaGxOvarian: Transcriptomic Ovarian Cancer Datasets

A collection of Ovarian Cancer Transcriptomic Datasets that are part of the MetaGxData package compendium.

Authors:Michael Zon [aut], Vandana Sandhu [aut], Christopher Eeles [ctb], Benjamin Haibe-Kains [aut, cre]

MetaGxOvarian_1.33.0.tar.gz
MetaGxOvarian_1.33.0.tar.gz(r-4.7-any)MetaGxOvarian_1.33.0.tar.gz(r-4.6-any)
manual.pdf |manual.html✨
DESCRIPTION |NEWS
card.svg |card.png
MetaGxOvarian/json (API)

# Install 'MetaGxOvarian' in R:
install.packages('MetaGxOvarian', repos = c('https://bioc.r-universe.dev', 'https://cloud.r-project.org'))

On BioConductor:MetaGxOvarian-1.33.0(data/experiment 3.24)MetaGxOvarian-1.32.0(data/experiment 3.23)

This package does not link to any Github/Gitlab/R-forge repository. No issue tracker or development information is available.

expressiondataexperimenthubcancerdatahomo_sapiens_dataarrayexpressgeoncimicroarraydataexperimentdatadatapkg

3.64 score 29 scripts 38 downloads 2 exports 69 dependencies

Last updated from:432564fa06. Checks:1 WARNING, 3 ERROR. Indexed: yes.

TargetResultTimeFilesSyslog
bioc-checksWARNING170
linux-develERROR335
source / vignettesERROR271
linux-releaseERROR349

Exports:loadOvarianDatasetsloadOvarianEsets

Dependencies:abindAnnotationDbiAnnotationHubaskpassBiobaseBiocBaseUtilsBiocFileCacheBiocGenericsBiocManagerBiocVersionBiostringsbitbit64blobcachemclicpp11crayoncurlDBIdbplyrDelayedArraydigestdplyrExperimentHubfastmapfilelockgenericsGenomicRangesgluehttrhttr2imputeIRangesjsonliteKEGGRESTlatticelifecyclemagrittrMatrixMatrixGenericsmatrixStatsmemoisemimeopensslpillarpkgconfigpngpurrrR6rappdirsrlangRSQLiteS4ArraysS4VectorsSeqinfoSparseArraystringistringrSummarizedExperimentsystibbletidyrtidyselectutf8vctrswithrXVectoryaml

Readme and manuals

Help Manual

Help pageTopics
days_to_deathattention
a list containing the names of patients that are believed to be dulicates across datasetsduplicates
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.E.MTAB.386
Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.GSE12418
Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.GSE12470
Survival-related profile, pathways, and transcription factors in ovarian cancer.GSE13876
A prognostic gene expression index in ovarian cancer - validation across different independent data sets.GSE14764
Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.GSE17260
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.GSE18520
Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.GSE19829
A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.GSE20565
IGC EXpression Project for OncologyGSE2109
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.GSE26193
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.GSE26712
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.GSE30009
Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.GSE30161
High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.GSE32062
High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.GSE32063
COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.GSE44104
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.GSE49997
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.GSE51088
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.GSE6008
Classification of ovarian tumor samplesGSE6822
Analysis of gene expression in early-stage ovarian cancer.GSE8842
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.GSE9891
Function to load ovarian cancer SummarizedExperiment objects from the Experiment HubloadOvarianDatasets
Function to load ovarian cancer expression sets from the Experiment HubloadOvarianEsets
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.PMID15897565
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.PMID17290060
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.PMID19318476
Integrated genomic analyses of ovarian carcinoma.TCGA.RNASeqV2
Integrated genomic analyses of ovarian carcinoma.TCGAOVARIAN